Cargando…
The association between EGFR variant III, HPV, p16, c-MET, EGFR gene copy number and response to EGFR inhibitors in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
BACKGROUND: We examine the potential prognostic and predictive roles of EGFR variant III mutation, EGFR gene copy number (GCN), human papillomavirus (HPV) infection, c-MET and p16(INK4A )protein expression in recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN). METHODS:...
Autores principales: | Chau, Nicole G, Perez-Ordonez, Bayardo, Zhang, Katherine, Pham, Nhu-An, Ho, James, Zhang, Tong, Ludkovski, Olga, Wang, Lisa, Chen, Eric X, Tsao, Ming-Sound, Kamel-Reid, Suzanne, Siu, Lillian L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3052237/ https://www.ncbi.nlm.nih.gov/pubmed/21352589 http://dx.doi.org/10.1186/1758-3284-3-11 |
Ejemplares similares
-
Effects of Ethnicity on Outcomes of Patients With EGFR Mutation–Positive NSCLC Treated With EGFR Tyrosine Kinase Inhibitors and Surgical Resection
por: Sung, Mike R., et al.
Publicado: (2021) -
EGFR gene copy number assessment from areas with highest EGFR expression predicts response to anti-EGFR therapy in colorectal cancer
por: Ålgars, A, et al.
Publicado: (2011) -
EGFR/Met association regulates EGFR TKI resistance in breast cancer
por: Mueller, Kelly L, et al.
Publicado: (2010) -
MET-EGFR dimerization in lung adenocarcinoma is dependent on EGFR mtations and altered by MET kinase inhibition
por: Ortiz-Zapater, Elena, et al.
Publicado: (2017) -
EGFR alterations and response to anti-EGFR therapy: is it a matter of gene amplification or gene copy number gain?
por: Sesboüé, R, et al.
Publicado: (2012)